Continuous subcutaneous insulin infusion (CSII) therapy utilizing insulin pumps continues to become popular among patients with diabetes.   Insulin pump therapy may be continued during the hospitalization period provided policies exist to ensure its safe use, which may involve a diabetes team familiar with CSII ... Read More »

Diabetes is a world-wide epidemic and complicates many hospitalizations.   Medical illness and surgery may lead to stress hyperglycemia in patients without pre-existing diabetes.     Both hyperglycemia and hypoglycemia are associated with increased inpatient morbidity and mortality and policies that promote ... Read More »

In the early 70s Dr. Archie Cochrane, in his landmark publication “Effectiveness and Efficiency” wisely stated: We need to ask 3 key questions about any kind of medical intervention: Can it Work?
Does it Work in practice?
Is it Worth it?
  ... Read More »

A persistent reduction in glomerular filtration rate (GFR) to less than 60ml per minute per 1.73 m has usually been the standard definition of chronic kidney disease (CKD). In every c ohort of type 2 diabetics followed-up for several years or decades 25 to 40% will develop CKD, and we don´t know yet all the reasons ... Read More »

Background :   For years it had been known that the insulin response to oral glucose was markedly greater that that seen after intravenous glucose even when the glucose concentrations were closely matched.   The search for these “Incretins” is one of the most exciting scientific adventures of the late ... Read More »